Gauri A. Patwardhan

1.5k total citations
21 papers, 1.1k citations indexed

About

Gauri A. Patwardhan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gauri A. Patwardhan has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Gauri A. Patwardhan's work include Sphingolipid Metabolism and Signaling (10 papers), Cancer Genomics and Diagnostics (4 papers) and Advanced Breast Cancer Therapies (2 papers). Gauri A. Patwardhan is often cited by papers focused on Sphingolipid Metabolism and Signaling (10 papers), Cancer Genomics and Diagnostics (4 papers) and Advanced Breast Cancer Therapies (2 papers). Gauri A. Patwardhan collaborates with scholars based in United States, Hungary and Germany. Gauri A. Patwardhan's co-authors include Yu Liu, S. Michal Jazwinski, Vineet K. Gupta, Leah J. Siskind, Levi J. Beverly, Myles C. Cabot, Vikram B. Wali, Lajos Pusztai, Christos Hatzis and Kaustubh N. Bhinge and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Gauri A. Patwardhan

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gauri A. Patwardhan United States 16 763 376 171 162 150 21 1.1k
Manjari Dimri United States 23 1.1k 1.4× 364 1.0× 169 1.0× 232 1.4× 209 1.4× 35 1.4k
Daniele Lecis Italy 23 862 1.1× 310 0.8× 203 1.2× 203 1.3× 90 0.6× 49 1.1k
Leisl Packer Australia 16 815 1.1× 333 0.9× 163 1.0× 112 0.7× 147 1.0× 28 1.1k
Jangsoon Lee United States 18 684 0.9× 434 1.2× 84 0.5× 166 1.0× 187 1.2× 40 1.1k
Debdutta Bandyopadhyay United States 20 1.1k 1.5× 488 1.3× 291 1.7× 176 1.1× 154 1.0× 34 1.6k
Huadong Pei United States 11 724 0.9× 309 0.8× 136 0.8× 205 1.3× 94 0.6× 16 1.0k
Sophie North France 16 768 1.0× 560 1.5× 102 0.6× 261 1.6× 123 0.8× 17 1.1k
Alejandro J. Urtreger Argentina 19 679 0.9× 306 0.8× 76 0.4× 214 1.3× 105 0.7× 41 1.0k
Olivia Gardner United States 13 669 0.9× 407 1.1× 136 0.8× 102 0.6× 78 0.5× 22 929
Hannie Sietsma Netherlands 19 751 1.0× 282 0.8× 104 0.6× 109 0.7× 132 0.9× 22 1.0k

Countries citing papers authored by Gauri A. Patwardhan

Since Specialization
Citations

This map shows the geographic impact of Gauri A. Patwardhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gauri A. Patwardhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gauri A. Patwardhan more than expected).

Fields of papers citing papers by Gauri A. Patwardhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gauri A. Patwardhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gauri A. Patwardhan. The network helps show where Gauri A. Patwardhan may publish in the future.

Co-authorship network of co-authors of Gauri A. Patwardhan

This figure shows the co-authorship network connecting the top 25 collaborators of Gauri A. Patwardhan. A scholar is included among the top collaborators of Gauri A. Patwardhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gauri A. Patwardhan. Gauri A. Patwardhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patwardhan, Gauri A., Michał Marczyk, Vikram B. Wali, et al.. (2021). Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations. npj Breast Cancer. 7(1). 21 indexed citations
2.
Marczyk, Michał, Gauri A. Patwardhan, Jun Zhao, et al.. (2020). Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells. Cancers. 12(9). 2551–2551. 15 indexed citations
3.
Wali, Vikram B., Gauri A. Patwardhan, Vasiliki Pelekanou, et al.. (2019). Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer. Scientific Reports. 9(1). 14934–14934. 18 indexed citations
4.
Hofstatter, Erin, Steve Horvath, D. Dalela, et al.. (2018). Increased epigenetic age in normal breast tissue from luminal breast cancer patients. Clinical Epigenetics. 10(1). 112–112. 37 indexed citations
5.
Székely, Borbála, Veerle Bossuyt, Xiaofeng Li, et al.. (2018). Immunological differences between primary and metastatic breast cancer. Annals of Oncology. 29(11). 2232–2239. 240 indexed citations
6.
Patwardhan, Gauri A., Vikram B. Wali, Lajos Pusztai, & Christos Hatzis. (2017). Abstract 2073: A systematic investigation of the effect of scheduling of targeted combination therapies on response and dynamics of relapse in triple negative breast cancer cells. Cancer Research. 77(13_Supplement). 2073–2073. 1 indexed citations
7.
Wali, Vikram B., Gauri A. Patwardhan, Christos Hatzis, & Lajos Pusztai. (2017). Abstract 1141: Evaluation of GABRP as a novel therapeutic target in triple negative breast cancer. Cancer Research. 77(13_Supplement). 1141–1141.
8.
Pérez‐Peña, Javier, Cristina Nieto‐Jiménez, Verónica Corrales‐Sánchez, et al.. (2017). Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors. Oncotarget. 8(13). 21733–21740. 15 indexed citations
9.
Wali, Vikram B., Casey G. Langdon, Matthew A. Held, et al.. (2016). Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer. Cancer Research. 77(2). 566–578. 38 indexed citations
10.
Chang, Kai‐Ti, Andriy Anishkin, Gauri A. Patwardhan, et al.. (2015). Ceramide channels: destabilization by Bcl-xL and role in apoptosis. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(10). 2374–2384. 49 indexed citations
11.
Patwardhan, Gauri A., Levi J. Beverly, & Leah J. Siskind. (2015). Sphingolipids and mitochondrial apoptosis. Journal of Bioenergetics and Biomembranes. 48(2). 153–168. 107 indexed citations
12.
Patwardhan, Gauri A., Salman B. Hosain, David X. Liu, et al.. (2014). Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1841(11). 1571–1580. 21 indexed citations
13.
Liu, Yu, Gauri A. Patwardhan, Kaustubh N. Bhinge, et al.. (2011). Suppression of Glucosylceramide Synthase Restores p53-Dependent Apoptosis in Mutant p53 Cancer Cells. Cancer Research. 71(6). 2276–2285. 69 indexed citations
14.
Patwardhan, Gauri A. & Yu Liu. (2010). Sphingolipids and expression regulation of genes in cancer. Progress in Lipid Research. 50(1). 104–114. 84 indexed citations
15.
Siddiqui, Akhtar, Gauri A. Patwardhan, Yu Liu, & Sami Nazzal. (2010). Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: In vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells. International Journal of Pharmaceutics. 400(1-2). 251–259. 17 indexed citations
16.
Liu, Yu, Vineet K. Gupta, Gauri A. Patwardhan, et al.. (2010). Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and β-catenin signaling. Molecular Cancer. 9(1). 145–145. 140 indexed citations
17.
Patwardhan, Gauri A., et al.. (2010). Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy. Biochemical Pharmacology. 80(1). 72–79. 23 indexed citations
18.
Patwardhan, Gauri A., Qian-Jin Zhang, Dongmei Yin, et al.. (2009). A New Mixed-Backbone Oligonucleotide against Glucosylceramide Synthase Sensitizes Multidrug-Resistant Tumors to Apoptosis. PLoS ONE. 4(9). e6938–e6938. 43 indexed citations
19.
Gupta, Vineet K., Gauri A. Patwardhan, Qian-Jin Zhang, et al.. (2009). Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase. Journal of Lipid Research. 51(4). 866–874. 30 indexed citations
20.
Liu, Yu, Jing Yu, Dongmei Yin, et al.. (2008). A role for ceramide in driving cancer cell resistance to doxorubicin. The FASEB Journal. 22(7). 2541–2551. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manjari Dimri Breakdown of academic impact, for papers by Daniele Lecis Breakdown of academic impact, for papers by Leisl Packer Breakdown of academic impact, for papers by Jangsoon Lee Breakdown of academic impact, for papers by Debdutta Bandyopadhyay Breakdown of academic impact, for papers by Huadong Pei Breakdown of academic impact, for papers by Sophie North Breakdown of academic impact, for papers by Alejandro J. Urtreger Breakdown of academic impact, for papers by Olivia Gardner Breakdown of academic impact, for papers by Hannie Sietsma
Rankless by CCL
2026